These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29754324)

  • 1. Cost-utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort.
    Forster R; Ratcliffe A; Lewis M; Crossley A; Bastida JL; Dunlop WCN
    Eur J Health Econ; 2018 Dec; 19(9):1303-1318. PubMed ID: 29754324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COST-effectiveness of salmeterol/fluticasone propionate combination (Advair(®)) in uncontrolled asthma in Canada.
    Ismaila AS; Risebrough N; Li C; Corriveau D; Hawkins N; FitzGerald JM; Su Z
    Respir Med; 2014 Sep; 108(9):1292-302. PubMed ID: 25175480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes.
    Price DB; Román-Rodríguez M; McQueen RB; Bosnic-Anticevich S; Carter V; Gruffydd-Jones K; Haughney J; Henrichsen S; Hutton C; Infantino A; Lavorini F; Law LM; Lisspers K; Papi A; Ryan D; Ställberg B; van der Molen T; Chrystyn H
    J Allergy Clin Immunol Pract; 2017; 5(4):1071-1081.e9. PubMed ID: 28286157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an economic model to assess the cost effectiveness of asthma management strategies.
    Price MJ; Briggs AH
    Pharmacoeconomics; 2002; 20(3):183-94. PubMed ID: 11929348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of BDP/formoterol fixed vs two single inhalers in asthma treatment.
    Brüggenjürgen B; Ezzat N; Kardos P; Buhl R
    Allergy; 2010 Sep; 65(9):1108-15. PubMed ID: 20121768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective.
    Paggiaro P; Patel S; Nicolini G; Pradelli L; Zaniolo O; Papi A
    Respir Med; 2013 Oct; 107(10):1531-7. PubMed ID: 23916740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: a simulation study.
    Zafari Z; Lynd LD; FitzGerald JM; Sadatsafavi M
    J Allergy Clin Immunol; 2014 Oct; 134(4):908-915.e3. PubMed ID: 24875619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma.
    Zafari Z; Sadatsafavi M; Marra CA; Chen W; FitzGerald JM
    PLoS One; 2016; 11(1):e0146003. PubMed ID: 26751790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaler Review in Older Adults with Asthma or COPD: A Cost-Effectiveness Study and a Perspective in Portugal.
    Maricoto T; Marques-Gomes J; Correia-de-Sousa J; Taborda-Barata L
    J Am Geriatr Soc; 2019 Jul; 67(7):1430-1436. PubMed ID: 30801670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus babyhaler spacer in the treatment of asthma in preschool-aged children.
    Bisgaard H; Price MJ; Maden C; Olsen NA
    Chest; 2001 Dec; 120(6):1835-42. PubMed ID: 11742910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of choice of inhalers for asthma care on global carbon footprint and societal costs: a long-term economic evaluation.
    Kponee-Shovein K; Marvel J; Ishikawa R; Choubey A; Kaur H; Ngom K; Fakih I; Swartz N; Schatzki T; Signorovitch J
    J Med Econ; 2022; 25(1):940-953. PubMed ID: 35686860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of omalizumab add-on to standard-of-care therapy in patients with uncontrolled severe allergic asthma in a Brazilian healthcare setting.
    Suzuki C; Lopes da Silva N; Kumar P; Pathak P; Ong SH
    J Med Econ; 2017 Aug; 20(8):832-839. PubMed ID: 28532191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and cost benefits associated with the introduction of inhaled corticosteroid therapy in a medicaid population of asthmatic patients.
    Balkrishnan R; Norwood GJ; Anderson A
    Clin Ther; 1998; 20(3):567-80. PubMed ID: 9663371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing the position and use of omalizumab for severe persistent allergic asthma using cost-effectiveness analysis.
    Faria R; McKenna C; Palmer S
    Value Health; 2014 Dec; 17(8):772-82. PubMed ID: 25498772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.
    De Vera MA; Sadatsafavi M; Tsao NW; Lynd LD; Lester R; Gastonguay L; Galo J; FitzGerald JM; Brasher P; Marra CA
    Trials; 2014 Dec; 15():488. PubMed ID: 25494702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma.
    Rodríguez-Martínez CE; Sossa-Briceño MP; Castro-Rodriguez JA
    J Asthma; 2013 May; 50(4):410-8. PubMed ID: 23356720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients.
    Björnsdóttir US; Gizurarson S; Sabale U
    Int J Clin Pract; 2013 Sep; 67(9):904-10. PubMed ID: 23773278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of a pharmacist-led information technology intervention for reducing rates of clinically important errors in medicines management in general practices (PINCER).
    Elliott RA; Putman KD; Franklin M; Annemans L; Verhaeghe N; Eden M; Hayre J; Rodgers S; Sheikh A; Avery AJ
    Pharmacoeconomics; 2014 Jun; 32(6):573-90. PubMed ID: 24639038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma.
    Buendía JA; Patiño DG
    BMC Pulm Med; 2021 Dec; 21(1):398. PubMed ID: 34865635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of asthma therapy: a comprehensive review.
    Domínguez-Ortega J; Phillips-Anglés E; Barranco P; Quirce S
    J Asthma; 2015; 52(6):529-37. PubMed ID: 25539023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.